DHA Omnibus IV
Omnibus IV Multiple Award Military Medical Research and Development ID/IQ
DHA IDIQ Active - Obligated to date
- $187.2M
- Task orders
- 107
- Contractors
- 56
- Ceiling
- $10 billion
Vehicle overview
The Omnibus IV Multiple Award Military Medical Research and Development IDIQ is a contract vehicle managed by the Defense Health Agency to advance medical research and development for the Department of Defense. It facilitates the discovery and integration of innovative medical knowledge and material solutions to improve Force health readiness, resilience, and rehabilitation. The vehicle features a $10 billion ceiling, 56 prime contract holders, and a 10-year ordering period. Following an OMB Tier 2 Designation in 2023, the contract is available for use by all government agencies to fulfill medical R&D requirements.
Work is organized into four market segments: Research and Development, R&D Support Services, Regulatory Processes, and Translational Science Support and Services. Program areas include medical simulation technologies, infectious diseases, radiation health effects, and chemical and biological readiness, with small business set-asides available at the task order level.
Vehicle details
- Ordering period
-
20 June 2022 through 19 June 2032
- Ceiling
-
$10 billion
Where agencies spend through DHA Omnibus IV
See which agencies and types of work reported the most positive obligations through DHA Omnibus IV in the last 12 months.
-
Department of Defense
- Last 12mo obligations
- $77.9M
- Last 12mo awards
- 40
Coverage period Jul 28, 2025–Jul 27, 2026
DHA Omnibus IV contract holders
| Contractor | Obligated | Task orders |
|---|---|---|
| LEIDOS, INC. | $43.8M | 7 |
| GOLDBELT C6, LLC | $23.7M | 5 |
| THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | $20.2M | 9 |
| KNOWESIS, INC. | $19.0M | 5 |
| KAPILI SERVICES, LLC | $16.6M | 7 |
| CULMEN INTERNATIONAL, LLC | $16.5M | 5 |
| CHEROKEE NATION OPERATIONAL SOLUTIONS, L.L.C. | $8.7M | 2 |
| ODYSSEY SYSTEMS CONSULTING GROUP, LTD. | $7.3M | 3 |
| PARSONS GOVERNMENT SERVICES INC. | $7.0M | 2 |
| TECHWERKS LLC | $5.7M | 5 |
| POTOMACWAVE, INC. | $5.0M | 2 |
| IRVING BURTON ASSOCIATES, LLC | $4.6M | 2 |
| APPLIED RESEARCH ASSOCIATES, INC. | $2.4M | 2 |
| ZCORE BUSINESS SOLUTIONS, INC | $1.7M | 3 |
| AXIOM RESOURCE MANAGEMENT, INC. | $1.5M | 2 |
Top 15 of 56 companies by obligations.
NAICS coverage
Frequently asked questions
- What is DHA Omnibus IV?
- The Omnibus IV Multiple Award Military Medical Research and Development IDIQ is a contract vehicle managed by the Defense Health Agency to advance medical research and development for the Department of Defense. It facilitates the discovery and integration of innovative medical knowledge and material solutions to improve Force health readiness, resilience, and rehabilitation. The vehicle features a $10 billion ceiling, 56 prime contract holders, and a 10-year ordering period. Following an OMB Tier 2 Designation in 2023, the contract is available for use by all government agencies to fulfill medical R&D requirements.
- Which agency manages DHA Omnibus IV?
- Omnibus IV Multiple Award Military Medical Research and Development ID/IQ is a IDIQ managed by Defense Health Agency.
- What can agencies acquire through DHA Omnibus IV?
- Work is organized into four market segments: Research and Development, R&D Support Services, Regulatory Processes, and Translational Science Support and Services. Program areas include medical simulation technologies, infectious diseases, radiation health effects, and chemical and biological readiness, with small business set-asides available at the task order level.
- How much has been obligated through DHA Omnibus IV?
- $187.2M has been obligated across 107 task orders.
- Which agencies use DHA Omnibus IV?
- In the 12 months ending July 27, 2026, agencies with reported awards through DHA Omnibus IV included the Department of Defense. The Department of Defense reported $77.9M in positive obligations for Research and Development in Biotechnology (except Nanobiotechnology) (NAICS 541714). Figures use reported USAspending award data.
- How many contractors hold DHA Omnibus IV?
- 56 contractors hold a position on DHA Omnibus IV.
- What is the contract ceiling of DHA Omnibus IV?
- DHA Omnibus IV has a program ceiling of $10 billion.
- Is DHA Omnibus IV active?
- Yes, DHA Omnibus IV is currently active (ordering period: 20 June 2022 through 19 June 2032).
Track the contracts behind DHA Omnibus IV
Sweetspot helps capture teams monitor awards, incumbents, recompetes, and agency demand across federal contract vehicles.
Schedule a Demo